
iwAL 2023 Session II: Novel treatments in AML: FLT3 inhibitors, combinations, and more
VJHemOnc Podcast
00:00
Introduction
Experts discuss the latest advancements in AML treatment, including FLT3 inhibitors and innovative combinations. The chapter also explores treatment options for relapsed patients and the significance of molecular information in determining the best approach.
Transcript
Play full episode